الفهرس | Only 14 pages are availabe for public view |
Abstract In our opinion, the most important criteria in the selection of a bariatric procedure remain the safety and efficacy in achieving both weight loss and remission of the metabolic consequences of obesity. Despite the intrinsic limitation imposed by a retrospective study, our results seem to confirm that LMGB is both safe and effective for the treatment of morbidly obese diabetic patients. Laparoscopic SASI bypass has been shown to be an effective, safe, and simple procedure for the treatment of morbid obesity and its associated metabolic consequences. Moreover, it results in minimal postoperative nutritional complications in comparison to other bariatric procedures. However, long-term follow-up period should be performed to evaluate postoperative weight loss, metabolic changes, and nutritional status of patients. Both MGB and LSG are safe, short, and simple operations. Weight loss is similar in MGB and LSG in the first years, but lesser %EWL with LSG at 5 years (68% in MGB versus 51 % in LSG). Post-operative GERD is more common after LSG. MGB has been fairly quickly and technically simpler and safer than other main stream bariatric operations. Leaks or bleeding are rare. The jejunal bypass length is modifiable with the degree of BMI and The MGB has shown durable weight loss and co-morbidity resolution. The single nonobstructing ante colic GJ anastomosis constructed in easy view provides a technically easy option for revision or reversal. This study confirms previous publications showing that MGB is quite safe, with a short hospital stay and low risk of complications. It results in effective and sustained weight loss with high resolution of comorbidities and complications that are easily managed. Patients with metabolic syndrome improved after gastric bypass, with results lasting after 2 years; other metabolic parameters important for cardiovascular risk were also positively affected. There was a relationship between the amount of weight loss and improvement of metabolic syndrome. SASI bypass is a promising operation that offers excellent weight loss and diabetic resolution. SASI bypass is a promising operation, based on digestive adaptation physiologic principles, easier to perform than the Santoro’s operation and BPD modifications, and with very good results as duodenal switch operation in the short run without mal-absorption morbidity. Both types of surgical procedures obtained similar T2DM remission rates, suggesting a high efficiency of both and making neither procedure preferable to the other. Both were seen to assist in the control of the diabetes and comorbidities. SASI bypass is a promising operation that offers excellent weight loss and metabolic result. The elimination of two ways for passage of food and one anastomosis decrease nutritional deficiency and the possibility of surgically related complications. Laparoscopic mini-gastric bypass (MGB) is a technically simple and safe procedure in SSO patients. LMGB has the advantages of being a single stage procedure, being easily reversible and revisable in a laparoscopic procedure and does not sacrifice portions of the stomach or implant foreign materials. |